GLP Winner

GLP-1 weight loss provider comparisons and pricing

health AI / digital health / telemedicine

Visit website

StagePre-Seed

Raised$250,000

Employees6

LocationAustin, TX

Business modelB2C / marketplace / information aggregator

Valuation$821,328

About

GLP Winner connects consumers with weight loss providers, focusing on GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Zepbound, compounded semaglutide, and compounded tirzepatide. We reduce friction and time to purchase by making the first tool to compare providers who are licensed in your state with transparent pricing. We help consumers understand compounded pharmacy licensing and provide transparency on which providers use which pharmacies.

Product

Value proposition: Transparent price comparisons and verified provider listings to make GLP-1 medications more accessible
Target customers: individuals seeking GLP-1 therapies and providers/pharmacies offering them

Founders

Sabina Hemmi — Co-Founder and CEO
Benson Tran — Co-Founder & CTO

Products

price comparison for GLP-1 therapiesprovider directorynew patient pricing offers

Key features

price comparisons for compounded and brand GLP-1 medicationsprovider listings with reviewsnew cash-pay pricingprior authorization support

Technologies

web platformlink aggregationprovider directory

Target conditions

obesityweight management

Care settings

virtualclinicpharmacy

Traction metrics

new cash-pay customers: $199/mo for the first 2 months, then $349/mo after (offer ends March 31, 2026)

Investors

Antler

News

GLP Winner 2026 Company Profile: Valuation, Funding & Investors · 2026-05-13T00:00:00.000Z
Safe Drugs Act & State Bills Threaten Compounded GLP-1 Access · 2026-02-12T00:00:00.000Z
Lauren P. · 2026-06-12T04:19:53.000Z
How one man used AI to build a fast‑growing company selling GLP-1 · 2026-04-05T00:00:00.000Z
Just About Anyone Can Sell You GLP-1s Online Now - WIRED · 2026-07-01T00:00:00.000Z
GLP-1 newcomer Remedy Meds to acquire Thirty Madison for $500M · 2025-09-04T18:30:00.000Z